CDMO MabPlex expands cGMP manufacturing facilities in China
MabPlex International is expanding its biomanufacturing facilities in China to meet biologic demand for “the foreseeable future.”
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs